InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the detailed record of transactions filed by Cannon, Gillian. Officer active across 1 company, notably Xenon Pharmaceuticals Inc.. Aggregated, 6 filings have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €39k. Activity tracked since 5 June 2026. The latest transaction was filed on 5 June 2026 (10 - Acquisition or disposition in the public market). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations
Gillian Cannon is a declarant linked to Xenon Pharmaceuticals Inc. (XNAS), where she is Director of Issuer. Across 6 filings in total, the sampled recent filings run from 2026-06-05 to 2026-06-09, with EUR 39321 of buys and EUR 0 of sells, and the most frequent transaction nature is 57 - Exercise of rights.